News
Novo Nordisk should perform well thanks to new leadership and a strong underlying business. Exelixis' main oncology franchise ...
From Novo Nordisk to UnitedHealth, onetime chief executives are returning to guide their former organizations in times of ...
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...
The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off ...
Years before Novo Nordisk's obesity drug Wegovy became a U.S. blockbuster, then-CEO Lars Rebien Sorensen told a press ...
Using Sernova Biotherapeutics' investigational Cell Pouch Bio-hybrid Organ, transplanted human donor islet cells helped ...
Regional equity markets closed in positive territory on Tuesday, building positive momentum after a muted trading session on ...
Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
Novo Nordisk announced on Friday morning that its CEO Lars Fruergaard Jørgensen is stepping down after leading the company for eight years. In a release announcing the decision, the Danish pharma ...
Asian shares are lower after Moody's Ratings downgraded the sovereign credit rating for the United States. U.S. futures and ...
Markets don't seem to have fully digested Moody's downgrade of the U.S. credit rating, Mitsubishi UFJ Morgan Stanley ...
HONG KONG (AP) — Asian shares fell Monday and U.S. futures and the dollar weakened after Moody’sRatings downgraded the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results